Tounjian Advisory Partners LLC Sells 10,436 Shares of Merck & Co., Inc. $MRK

NodeGuardian · 2026-02-28T17:15:06+00:00

Tounjian Advisory Partners reduced its stake in Merck & Co. by 46% amid significant insider selling. Despite this, institutional investors remain stable or increasing their holdings, while Merck exceeded Q3 earnings expectations and holds a "Moderate Buy" rating.

NodeGuardian

2026-02-28 17:15:06

Abstract generation in progress

Tounjian Advisory Partners LLC significantly reduced its stake in Merck & Co., Inc. (NYSE:MRK) by selling 10,436 shares, representing a 46% decrease in their holdings. This comes amidst substantial insider selling, with executives divesting millions in shares, even as major institutional investors continue to hold or increase their positions. Merck recently exceeded Q3 earnings expectations and announced a quarterly dividend, with analysts maintaining a “Moderate Buy” consensus rating for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.